Carlisle Companies Incorporated (CSL)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,772,700 1,732,500 1,753,800 775,100 684,500 736,100 725,200 832,100 924,000 877,900 765,300 563,100 421,700 374,200 334,400 310,500 320,100 342,100 377,700 455,200
Revenue (ttm) US$ in thousands 5,003,600 5,008,200 4,934,400 5,009,700 4,805,800 5,132,900 5,667,200 5,988,200 6,591,900 6,513,300 6,034,800 5,365,700 4,810,300 4,498,400 4,309,500 4,155,900 4,245,200 4,325,400 4,479,300 4,769,900
Net profit margin 35.43% 34.59% 35.54% 15.47% 14.24% 14.34% 12.80% 13.90% 14.02% 13.48% 12.68% 10.49% 8.77% 8.32% 7.76% 7.47% 7.54% 7.91% 8.43% 9.54%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $1,772,700K ÷ $5,003,600K
= 35.43%

The net profit margin of Carlisle Companies Incorporated has shown a fluctuating trend over the periods provided. Initially, from March 2020 to September 2021, the net profit margin exhibited a gradual decline from 9.54% to 7.91%. However, from December 2021 onwards, there was a consistent increase in the net profit margin, reaching a peak of 35.54% in June 2024, before slightly decreasing to 35.43% by December 2024.

The significant increase in net profit margin from March 2024 to December 2024 suggests an improvement in the company's profitability efficiency. It is essential to monitor future periods to assess whether this elevated margin can be sustained or if there will be further fluctuations.

Overall, the recent surge in net profit margin indicates positive momentum for Carlisle Companies Incorporated, highlighting potential strengths in its operational performance and cost management strategies.


Peer comparison

Dec 31, 2024

Company name
Symbol
Net profit margin
Carlisle Companies Incorporated
CSL
35.43%
West Pharmaceutical Services Inc
WST
17.03%